Medical Health & Life Science Research News

Recent research: Drug screening market dominated by drug & alcohol consumption worldwide by 2022

Medical and Health

The drug screening market represents significant growth opportunities, market growth may be hindered due to prohibition of drug testing at workplace in certain regions, and ban on alcohol consumption in Islamic countries. Market is highly competitive with presence of several big and small players.

Prominent players offering drug screening products include Alere (US), Thermo Fisher (US), Drägerwerk (Germany), OraSure (US), Alfa Scientific Designs (US), Lifeloc (US), MPD, Inc. (US), Premier Biotech (US), Shimadzu (Japan), Siemens Healthineers (US). While, LabCorp (US), Quest Diagnostics (US), Omega Laboratories (US), Psychemedics (US), CRL (US), SureHire (Canada), and CannAmm (Canada) are some of key players offering drug screening services.

Drug Screening Market Research Sample Papers Available Now at www.reportsnreports.com/contact…ame=345782 .

The drug screening market is expected to reach USD 8.63 billion by 2022 from USD 5.32 billion in 2017, at a CAGR of 10.2%. Growing drug & alcohol consumption, enforcement of stringent laws mandating drug and alcohol testing, and the presence of government funding in major markets are factors driving the growth of the drug screening market.

Drug Screening Market, By Sample Type

1 Introduction

2 Urine Samples

3 Breath Samples

4 Oral Fluid Samples

5 Hair Samples

Drug Screening Market, By End User

1 Introduction

2 Workplace

3 Criminal Justice Systems and Law Enforcement Agencies

4 Drug Treatment Centers

5 Pain Management Centers

6 Schools and Colleges

7 Hospitals

8 Individual Users

9 Drug Testing Laboratories

Click Here For More Information on Drug Screening Market at with Top Trends and Company Profiles at www.reportsnreports.com/contact…ame=345782 .

North America is expected to account for the largest share of the market followed by Europe. However, Asia is expected to register the highest CAGR during the forecast period.

The high growth in this regional segment is attributed to the growing consumption of illicit drugs, rising number of drunk-driving cases, growing awareness regarding drug screening tests and the strategic expansion of the market players in the region.

Target Audience for this Report:

  • Drug and alcohol testing laboratories
  • Drug and alcohol testing product manufacturing companies
  • Rapid drug screening device manufacturers
  • Law enforcement agencies
  • Healthcare providers
  • Government agencies
  • Research and consulting firms
  • Venture capitalists

Get “Drug Screening Market by Product ((Immunoassay Analyzer, Chromatography, Breathalyzer, Rapid Test Device, Assay Kits)), Drug Screening Services, Sample Type (Urine, Hair, Oral), End User (Workplace, Criminal Justice, Hospital) - Global Forecast to 2022” report at www.reportsnreports.com/contact…ame=345782 .

The study estimates the drug screening market size for 2017 and projects its demand till 2022. In the primary research process, various sources from both demand side and supply side were interviewed to obtain qualitative and quantitative information for the report.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 – 23%; Tier 2 -32%; Tier 3 - 45%.
  • By Designation: C-level- 21%; D-level- 36%; others--43%.
  • By Region: North America-42%; Europe-37%; Asia Pacific-17%; RoW-4%.

News From

ReportsnReports - Industry Trends & ForecastsReportsnReports
Category: Market Research Publishers and RetailersCompany about: ReportsnReports.com provides market research reports to industries, individuals and organizations with an objective of helping them in their decision-making process. Our library of 400,000+ industry & country research reports covers 5000+ micro markets. Email us at This email address is being protected from spambots. You need JavaScript enabled to view it..
This email address is being protected from spambots. You need JavaScript enabled to view it.